| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.675 | 18.128 | 15.252 | 3.439 | 25.853 | 28.611 | 32.642 | 34.519 | 26.348 | 36.260 |
| Total Income - EUR | 10.393 | 18.533 | 15.252 | 3.515 | 25.927 | 28.611 | 275.554 | 49.919 | 26.412 | 44.402 |
| Total Expenses - EUR | 2.003 | 5.670 | 7.452 | 26.967 | 24.357 | 26.085 | 166.137 | 36.113 | 23.849 | 24.402 |
| Gross Profit/Loss - EUR | 8.390 | 12.863 | 7.800 | -23.452 | 1.570 | 2.526 | 109.417 | 13.807 | 2.563 | 20.000 |
| Net Profit/Loss - EUR | 8.078 | 12.306 | 7.342 | -23.487 | 1.311 | 2.240 | 106.670 | 13.307 | 2.299 | 19.556 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Viflux Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 235.995 | 233.588 | 229.636 | 487.832 | 462.597 | 443.405 | 271.327 | 290.885 | 330.236 | 419.113 |
| Current Assets | 46.043 | 34.262 | 33.031 | 23.327 | 39.337 | 52.086 | 193.714 | 77.968 | 81.138 | 23.261 |
| Inventories | 0 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 6.201 | 5.002 | 7.603 | 6.727 | 29.052 | 35.896 | 31.629 | 61.169 | 57.185 | 1.734 |
| Cash | 39.842 | 29.240 | 25.428 | 16.600 | 10.285 | 16.190 | 162.085 | 16.799 | 23.953 | 21.527 |
| Shareholders Funds | 93.471 | 104.824 | 110.392 | 84.879 | 84.546 | 85.183 | 149.194 | 162.964 | 165.088 | 183.721 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 4.245 | 4.258 | 4.245 | 4.222 |
| Debts | 188.568 | 163.027 | 152.274 | 426.280 | 417.388 | 410.308 | 315.847 | 205.889 | 246.286 | 258.653 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Viflux Intermed Srl